Home > Clinical Trials by Conditions > "A" Clinical Trial Conditions > Atherosclerosis Clinical Trials
Atherosclerosis Clinical Trials
A blinded study conducted at multiple centers evaluating various doses of an investigational agent (BO-653) against placebo, for safety and effectiveness in preventing post-angioplasty blood vessel re-closure (restenosis) in stented vessels.
Condition: chugai_pharma_usa_clinical_trials.html
Chugai Pharma USA
Antioxidants and Prevention of Early Atherosclerosis
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Apolipoprotein A-I Gene Polymorphism and Atherosclerosis
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
ARISE - Aggressive Reduction of Inflammation Stops Events
Condition: atherogenics_clinical_trials.html
AtheroGenics
Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Bogalusa Heart Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular Evaluation of Patients with High Cholesterol and Normal Volunteers
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular Risk Profile Among Mexican-Americans
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Carotid Artery Thickness in HIV Infected and Uninfected Adults
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Central Obesity and Disease Risk in Japanese Americans
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cholesterol Reduction in Seniors Program (CRISP)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Comparative Efficacy Evaluation of Lipids when Treated with Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Condition: kos_pharmaceuticals_clinical_trials.html
Kos Pharmaceuticals
Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis
Condition: warren_g_magnuson_clinical_center_cc_clinical_trials.html
Warren G Magnuson Clinical Center (CC)
Computed Tomography (CT)--An Epidemiologic Study in the Young
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Does the reduction of Total Body Iron Storage (TBIS) alter mortality in a population of patients with advanced PVD.
Condition: department_of_veterans_affairs_clinical_trials.html
Department of Veterans Affairs
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women with Chronic Infections
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Carotid Artery Atherosclerosis in Youth
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Carotid Disease in Elderly Adults
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Coronary Artery Calcification
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Coronary Heart Disease in Men Aged 40 and Over
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients with Dyslipidemia (OCEANS)
Condition: kos_pharmaceuticals_clinical_trials.html
Kos Pharmaceuticals
Family Heart Study (FHS)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Framingham Cycle V Offspring-Spouse Nutrition Studies
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetic Architecture of Plasma T-PA and PAI-1
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetic Determinants:Low HDL, High Triglycerides, Obesity
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetic Epidemiology of Lipoprotein-Lipid Levels
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetic Mapping of Atherogenic Lipoprotein Phenotypes
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Homocysteine and Progression of Atherosclerosis
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Infection and Cardiovascular Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Insulin Resistance Atherosclerosis Study (IRAS)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Jackson Heart Study (JHS)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Lipoprotein Metabolism in Normal Volunteers and Patients with High Levels of Lipoproteins
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Longitudinal LDL-C Studies in Black and White Families
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Macronutrients and Cardiovascular Risk
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis
Condition: warren_g_magnuson_clinical_center_cc_clinical_trials.html
Warren G Magnuson Clinical Center (CC)
Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Molecular & Clinical Evaluation of Low HDL Syndromes
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Multi-Ethnic Study of Atherosclerosis (MESA)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Natural History of Peripheral Arterial Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Pawtucket Heart Health Program
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Atherosclerosis Clinical Trials
|
